A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease

Table 2 Test of within-subject contrast (change from baseline and change from previous year) for estimated glomerular filtration rate and total urinary protein

	Variable	Measure	Year	F	P value
Change from baseline	Year1 treatment	eGFR	year 1 vs baseline1	0.63	0.530
			year 2 vs baseline	0.46	0.632
			year 3 vs baseline	2.16	0.119
		TUP	year 1 vs baseline	6.00	0.003
			year 2 vs baseline	4.16	0.018
			year 3 vs baseline	0.90	0.409
Change from previous year	Year1 treatment	eGFR	year 1 vs baseline1	0.63	0.536
			year 2 vs year 1	0.03	0.967
			year 3 vs year 2	2.93	0.057
		TUP	year 1 vs baseline	6.01	0.003
			year 2 vs year 1	0.16	0.851
			year 3 vs year 2	3.11	0.048

¹Each row of the table tests the change from baseline to that time between the 4 groups. eGFR: Estimated glomerular filtration rate; TUP: Total urinary protein.